Extending value long after the clinical trial with real-world data
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
Historically, pharmaceutical manufacturers leveraged retail pharmacy prescriptions to identify...
As real-world data (RWD) continues to be increasingly utilized by the pharmaceutical industry and...
Medicaid provides much-needed healthcare coverage to over 70 million people, almost half of whom...
The use of real-world data (RWD) in pharmaceutical development is becoming increasingly prevalent...
With the start of 2024, we are moving toward a world without third-party cookies to track consumer...
With recent disruptions in the availability of real-world data (RWD) for clinical research,...
While the CDC is considered the nation’s leading authority on infectious diseases, it is also...
With advances in artificial intelligence (AI) making headlines almost daily, the life sciences...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly changing the landscape of life sciences, offering powerful tools for streamlining clinical trials, optimizing drug development, and enhancing regulatory ...